Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23K Sell
178
-31
-15% -$3.63K ﹤0.01% 191
2026
Q1
$24.7K Buy
209
+59
+39% +$6.81K 0.01% 167
2025
Q4
$15.9K Buy
+150
New +$14.1K 0.01% 168

Other funds holding MRK

Atomic Invest's MRK Position: Q2 2026 in Review

Atomic Invest reduced its Merck (MRK) stake by 15% in Q2 2026, selling an estimated $3.63K and leaving 178 shares worth $23K. The position accounts for ﹤0.01% of the portfolio, ranked #191.

Atomic Invest first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. The position peaked at $24.7K in Q1 2026. 3,851 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Atomic Invest held 178 shares of Merck worth $23K as of Q2 2026.
  • Atomic Invest sold 31 Merck shares in Q2 2026, an estimated $3.63K.
  • Merck made up ﹤0.01% of Atomic Invest's portfolio in Q2 2026, its #191 holding.
  • Atomic Invest first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • Atomic Invest's Merck position peaked at $24.7K in Q1 2026.
  • 3,851 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Atomic Invest's 13F filing for Q2 2026, filed 25 Sep 2026.